Full-Time

Territory Leader

Rhode Island

Confirmed live in the last 24 hours

Tarsus Pharamceuticals

Tarsus Pharamceuticals

201-500 employees

Biopharmaceuticals for eye and infectious diseases

Biotechnology
Healthcare

Compensation Overview

$105k - $148kAnnually

+ Incentive Bonus + Stock Equity

Junior, Mid

Providence, RI, USA

Candidates must live in Providence or Norwich.

Category
Field Sales
Sales & Account Management
Required Skills
Data Analysis
Requirements
  • Bachelor’s degree in business, science, or related field or commensurate experience
  • 2+ years pharmaceutical sales / relevant healthcare sales experience or a proven track record of business to business sales - required
  • Proven track record of pharmaceutical launch experience - strongly preferred
  • Eye Care experience- preferred
  • Established track record with evidence of excellent problem solving and collaboration
  • Highly adaptable to change, able to quickly pivot and respond given new market information in a fast-paced environment
  • Strong communication and change management skills
  • Proven ability to escalate difficult issues and make tough decisions
  • Established track record in the following job competencies: Selling skills, High performance, Impact & influence, Customer focus & account management, Maximizing resources, Analytical skills, Relationship building, Decision making & judgment, Teamwork & collaboration, Adaptability & GRIT
Responsibilities
  • Experts in eye care clinical information: anatomy, disease state, products, *XDEMVY* and office treatment patterns
  • Experts in selling skills and account development including building relationships with all key stakeholders
  • Experts in pull through tactics with a full understanding of managed care hurdles
  • Understand all functions within an ophthalmology/optometry practice and how their roles impact product prescribing and pull through
  • Maximize managed care opportunities within the territory and have an understanding of how it impacts the District, Region and Nation and share important feedback
  • Understand key opinion leaders within respective geographies and foster engagement with Tarsus leadership
  • As eye care experts, champion compliant promotion in alignment with our corporate values
  • Drive top tier execution by exceeding sales performance goals and key productivity metrics across the territory
  • Use expert analytical skills to guide highly productive activity – prioritize key customer engagements, drive reach and frequency to extend depth and breadth of product trial and utilization
  • Drive a successful launch and ongoing performance by monitoring all key performance metrics weekly, monthly, quarterly, and annually – ability to adjust approach as needed based on data
  • Ensure actionable business plans are set - align all selling activities to drive impact
  • Share ongoing insights with leadership and internal stakeholders to ensure feedback is captured
  • Personal accountability for driving the highest standards of ethics and compliance
  • Drive our culture of commitment, empowerment and teamwork which includes extreme ownership, high accountability, continuous improvement and relentless pursuit of excellence
  • Achieve success and be prepared to adapt in a complex selling environment partnering with many stakeholders: district leaders, marketing, market access, medical affairs, sales ops, inside sales, training, and other important stakeholders
  • Provide frontline feedback and intel to sales leadership and the broader organization
  • Ensure PDMA compliance and adhere to all company & industry compliance guidelines
  • Share ongoing best practices among peers and leadership to elevate national performance
  • Maximize all key resources that lead to territory success
Tarsus Pharamceuticals

Tarsus Pharamceuticals

View

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution for treating Demodex Blepharitis, a condition affecting the eyelids. The company also has a pipeline of potential treatments for other conditions, including Lyme Disease Prevention and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong commitment to ethical practices and compliance. Their goal is to improve patient outcomes by providing effective treatments for conditions that currently have limited options.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

Irvine, California

Founded

2017

Growth & Insights
Headcount

6 month growth

25%

1 year growth

33%

2 year growth

236%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $200 million in non-dilutive financing from Pharmakon Advisors strengthens Tarsus's financial position, enabling further R&D and market expansion.
  • Positive Phase 2a trial results for TP-05 for Lyme Disease prevention indicate promising future product offerings and potential market growth.
  • Recognition through awards like the Zero to Launch Award highlights Tarsus's innovative approach and successful commercialization strategies.

What critics are saying

  • The biopharmaceutical market is highly competitive and capital-intensive, requiring continuous innovation and substantial investment to maintain a competitive edge.
  • Dependence on the success of a limited number of products, such as XDEMVY, makes the company vulnerable to market fluctuations and regulatory changes.

What makes Tarsus Pharamceuticals unique

  • Tarsus Pharmaceuticals focuses on high unmet medical needs in eye care and infectious diseases, setting it apart from competitors with broader but less specialized portfolios.
  • Their flagship product, XDEMVY, is FDA-approved for treating Demodex Blepharitis, a niche condition with limited treatment options, giving them a unique market position.
  • The company's commitment to ethical operations and robust compliance programs ensures trust and reliability among healthcare providers and patients.

Help us improve and share your feedback! Did you find this helpful?